Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. BioLight Life Sciences Ltd.
  6. Summary
    BOLT   IL0010952237

BIOLIGHT LIFE SCIENCES LTD.

(BOLT)
Delayed Quote. Delayed TEL AVIV STOCK EXCHANGE - 06/24 05:27:49 am
1144 ILa   +0.26%
 SummaryQuotesChartsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
06/20/2021 06/21/2021 06/22/2021 06/23/2021 06/24/2021 Date
1100(c) 1091(c) 1141(c) 1141(c) 1144 Last
1 599 662 1 253 0 4 796 Volume
-2.65% -0.82% +4.58% 0.00% +0.26% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -12,6 M -3,87 M -3,87 M
Net cash position 2019 39,5 M 12,1 M 12,1 M
P/E ratio 2019 -3,01x
Yield 2019 -
Sales 2020 0,03  0,01  0,01 
Net income 2020 -13,4 M -4,11 M -4,11 M
Net cash position 2020 50,2 M 15,4 M 15,4 M
P/E ratio 2020 -2,56x
Yield 2020 -
Capitalization 51,8 M 15,9 M 15,9 M
EV / Sales 2019 -
EV / Sales 2020 -512 472 290x
Nbr of Employees 5
Free-Float 42,8%
More Financials
Company
Biolight Life Sciences Ltd, formerly Bio Light Israeli Life Sciences Investments Ltd, is an Israel-based company engaged, through its subsidiaries, in various fields of research and development of pharmaceuticals and medical products and devices. Its portfolio companies are IOptima Novel Glaucoma Treatment and Micromedic Technologies Ltd. The Company provides each of the subsidiaries with ongoing support, resources... 
More about the company
All news about BIOLIGHT LIFE SCIENCES LTD.

- No features available -

More news
News in other languages on BIOLIGHT LIFE SCIENCES LTD.

- No features available -

More news
Chart BIOLIGHT LIFE SCIENCES LTD.
Duration : Period :
BioLight Life Sciences Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Yaacov Michlin Chief Executive Officer
Itai Bar-Natan Chief Financial Officer
Israel Makov Chairman
Ron Neumann Chief Medical Officer
Ron Abraham Mayron Independent Director
Sector and Competitors